Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Questex Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Development deals
Biotech
Sanofi makes $75M preclinical bet to join busy Parkinson's field
The Big Pharma has claimed a spot toward the back of the pack by paying $75 million upfront for the global rights to a preclinical bispecific.
Nick Paul Taylor
Jan 12, 2022 8:45am
Amgen teams up with Arrakis in $75M RNA-destroying research deal
Jan 11, 2022 9:00am
Pfizer locks in 2 partners to solidify status as mRNA powerhouse
Jan 10, 2022 6:50am
Verily links up with Sosei Heptares for GPCR drug discovery
Jan 6, 2022 3:30pm
Pfizer, BioNTech team up against GSK's Shingrix dominance
Jan 5, 2022 9:49am
Novartis pays UCB $150M to join Roche in Parkinson's race
Dec 2, 2021 8:00am
